Repurpose an FDA‐Approved Antibody Using DARPin‐Scaffolded Bridge Protein

Documenti analoghi

• Structure‐Guided Repurposing of FDA‐Approved Drugs Targeting CCR2 for Immune Cell‐Mediated Neuropathic Pain
  di: Muath Suliman, et al.
  Pubblicazione: (2025)
• Repurposing of FDA‐Approved Drugs as Acetylcholinesterase Inhibitors for Alzheimer's Disease: A Combined In Silico and In Vitro Evaluation and Structure–Activity Relationship
  di: Merve Sıkık, et al.
  Pubblicazione: (2025)
• Ensemble Docking of FDA‐Approved and Peruvian Phytochemicals Against Monkeypox Virus Telomere‐Binding Protein
  di: Edinson Gervacio‐Villarreal, et al.
  Pubblicazione: (2026)
• Molecular Structures and Molecular Interactions of Peptides and Proteins at Buried Interfaces Studied Using Sum Frequency Generation Vibrational Spectroscopy
  di: Zahra Asif Gandhi, et al.
  Pubblicazione: (2026)
• Computational Screening of FDA‐Approved PPIs and PCABs against LasR Protein: Insights into Quorum Sensing Inhibition
  di: Uttam Paswan, et al.
  Pubblicazione: (2025)